Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Heirman

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Gene Medicine|February 5, 2005
Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapyAude Bonehill, Carlo Heirman, Kris Thielemans
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
Engineering WT1-Encoding mRNA to Increase Translational Efficiency in Dendritic CellsDaphné Benteyn, Carlo Heirman, Kris Thielemans, et al.
The Journal of Gene Medicine|October 7, 2004
Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cellsKarine Breckpot, Carlo Heirman, Bart Neyns, et al.
Human Vaccines & Immunotherapeutics|January 8, 2013
mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeuticSandra Van Lint, Carlo Heirman, Kris Thielemans, et al.
Expert Review of Vaccines|September 9, 2014
mRNA-based dendritic cell vaccinesDaphné Benteyn, Carlo Heirman, Aude Bonehill, et al.
Current Gene Therapy|June 13, 2009
In search of the most suitable lentiviral shRNA systemTomas Jan Bos, Elke De Bruyne, Carlo Heirman, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccinationAnnelies Michiels, Sandra Tuyaerts, Aude Bonehill, et al.
Human Gene Therapy|June 20, 2007
Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectorsKarine Breckpot, Perpetua Emeagi, Melissa Dullaers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2005
In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cellsSonja Van Meirvenne, Melissa Dullaers, Carlo Heirman, et al.
Journal of Biotechnology|July 20, 2010
Large double copy vectors are functional but show a size-dependent decline in transduction efficiencyTomas J Bos, Elke De Bruyne, Sandra Van Lint, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Gene Medicine|February 5, 2005
Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapyAude Bonehill, Carlo Heirman, Kris Thielemans
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
Engineering WT1-Encoding mRNA to Increase Translational Efficiency in Dendritic CellsDaphné Benteyn, Carlo Heirman, Kris Thielemans, et al.
The Journal of Gene Medicine|October 7, 2004
Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cellsKarine Breckpot, Carlo Heirman, Bart Neyns, et al.
Human Vaccines & Immunotherapeutics|January 8, 2013
mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeuticSandra Van Lint, Carlo Heirman, Kris Thielemans, et al.
Expert Review of Vaccines|September 9, 2014
mRNA-based dendritic cell vaccinesDaphné Benteyn, Carlo Heirman, Aude Bonehill, et al.
Current Gene Therapy|June 13, 2009
In search of the most suitable lentiviral shRNA systemTomas Jan Bos, Elke De Bruyne, Carlo Heirman, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccinationAnnelies Michiels, Sandra Tuyaerts, Aude Bonehill, et al.
Human Gene Therapy|June 20, 2007
Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectorsKarine Breckpot, Perpetua Emeagi, Melissa Dullaers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2005
In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cellsSonja Van Meirvenne, Melissa Dullaers, Carlo Heirman, et al.
Journal of Biotechnology|July 20, 2010
Large double copy vectors are functional but show a size-dependent decline in transduction efficiencyTomas J Bos, Elke De Bruyne, Sandra Van Lint, et al.
Pageof 8